London MEP Marina Yannakoudakis visited Johnson & Johnson’s Innovation Centre in London, one of four regional hubs established this year to accelerate innovation across the healthcare landscape.

The centres promote collaboration between the world’s leading scientists and entrepreneurs. Johnson & Johnson chose London for its European hub as the UK is home to one of the world’s thriving life sciences ecosystems.

Marina said: “I welcome Johnson & Johnson’s investment in London. The centre will enable scientists, entrepreneurs and emerging companies to work together to increase innovation across the pharmaceutical, medical device & diagnostics fields.”

Marina also discussed the ongoing deliberations on the EU’s revision of the Medical Devices Directive, for which she is one of the lead negotiators. Johnson & Johnson produces several innovative medical devices, a number of which are manufactured in the UK. Johnson & Johnson agrees with Marina’s approach to ensure that EU rules prioritise patient safety while not stifling innovation.